DE60010333D1 - Substituierte oxazole und thiazole derivate als hppar-alpha aktivatore - Google Patents
Substituierte oxazole und thiazole derivate als hppar-alpha aktivatoreInfo
- Publication number
- DE60010333D1 DE60010333D1 DE60010333T DE60010333T DE60010333D1 DE 60010333 D1 DE60010333 D1 DE 60010333D1 DE 60010333 T DE60010333 T DE 60010333T DE 60010333 T DE60010333 T DE 60010333T DE 60010333 D1 DE60010333 D1 DE 60010333D1
- Authority
- DE
- Germany
- Prior art keywords
- activatore
- hppar
- alpha
- thiazole derivatives
- substituted oxazole
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Child & Adolescent Psychology (AREA)
- Rheumatology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9928561.1A GB9928561D0 (en) | 1999-12-02 | 1999-12-02 | Chemical compounds |
GB9928561 | 1999-12-02 | ||
GB0003500 | 2000-02-15 | ||
GB0003500A GB0003500D0 (en) | 2000-02-15 | 2000-02-15 | Chemical compounds |
PCT/EP2000/011995 WO2001040207A1 (en) | 1999-12-02 | 2000-11-30 | Substituted oxazoles and thiazoles derivatives as hppar alpha activators |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60010333D1 true DE60010333D1 (de) | 2004-06-03 |
DE60010333T2 DE60010333T2 (de) | 2005-06-16 |
Family
ID=26243654
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60010333T Expired - Lifetime DE60010333T2 (de) | 1999-12-02 | 2000-11-30 | Substituierte oxazole und thiazole derivate als hppar-alpha aktivatore |
Country Status (27)
Country | Link |
---|---|
US (1) | US6518290B1 (de) |
EP (1) | EP1244642B1 (de) |
JP (1) | JP3884290B2 (de) |
KR (1) | KR100706735B1 (de) |
CN (1) | CN1184215C (de) |
AR (1) | AR035631A1 (de) |
AT (1) | ATE265442T1 (de) |
AU (1) | AU758758B2 (de) |
BR (1) | BR0016067A (de) |
CA (1) | CA2393190A1 (de) |
CO (1) | CO5251452A1 (de) |
CZ (1) | CZ20021903A3 (de) |
DE (1) | DE60010333T2 (de) |
DK (1) | DK1244642T3 (de) |
ES (1) | ES2219423T3 (de) |
GC (1) | GC0000215A (de) |
HK (1) | HK1047435B (de) |
HU (1) | HUP0203532A3 (de) |
IL (2) | IL149582A0 (de) |
MX (1) | MXPA02005456A (de) |
NO (1) | NO323135B1 (de) |
PE (1) | PE20011010A1 (de) |
PL (1) | PL356772A1 (de) |
PT (1) | PT1244642E (de) |
TR (2) | TR200201473T2 (de) |
TW (1) | TW555753B (de) |
WO (1) | WO2001040207A1 (de) |
Families Citing this family (66)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1317885B1 (it) * | 2000-08-01 | 2003-07-15 | Sigma Tau Ind Farmaceuti | Uso di fibrati per la preparazione di un medicamento utile neltrattamento dell'insufficienza cardiaca congestizia. |
WO2002014291A1 (en) | 2000-08-11 | 2002-02-21 | Nippon Chemiphar Co.,Ltd. | PPARδ ACTIVATORS |
UA82048C2 (uk) | 2000-11-10 | 2008-03-11 | Эли Лилли Энд Компани | Агоністи альфа-рецепторів, активованих проліфератором пероксисом |
GB0031107D0 (en) * | 2000-12-20 | 2001-01-31 | Glaxo Group Ltd | Chemical compounds |
EP1345916A1 (de) * | 2000-12-20 | 2003-09-24 | Glaxo Group Limited | Substituierte oxazole und thiazole als hppar alpha agonisten |
GB0031103D0 (en) * | 2000-12-20 | 2001-01-31 | Glaxo Group Ltd | Chemical compounds |
GB0031109D0 (en) * | 2000-12-20 | 2001-01-31 | Glaxo Group Ltd | Chemical compounds |
US7105551B2 (en) * | 2000-12-20 | 2006-09-12 | Smithkline Beecham Corporation | Thiazole derivatives for treating PPAR related disorders |
US20040072838A1 (en) | 2000-12-20 | 2004-04-15 | Pierette Banker | Thiazole and oxazole derivatives as activators of human peroxisome proliferator activated receptors |
GB0113231D0 (en) * | 2001-05-31 | 2001-07-25 | Glaxo Group Ltd | Chemical compounds |
GB0113232D0 (en) | 2001-05-31 | 2001-07-25 | Glaxo Group Ltd | Chemical process |
GB0113233D0 (en) | 2001-05-31 | 2001-07-25 | Glaxo Group Ltd | Chemical compounds |
JP4421895B2 (ja) * | 2001-08-10 | 2010-02-24 | 日本ケミファ株式会社 | ペルオキシソーム増殖剤応答性受容体δの活性化剤 |
PE20030547A1 (es) * | 2001-09-24 | 2003-08-18 | Bayer Corp | Derivados de imidazol para el tratamiento de la obesidad |
EP1435951B1 (de) * | 2001-10-12 | 2006-01-18 | Bayer Pharmaceuticals Corporation | Phenyl substituierte 5-gliedrige stickstoff enthaltende heterocyclen zur behandlung von fettleibigkeit |
AU2003224632A1 (en) | 2002-03-01 | 2003-09-16 | Smithkline Beecham Corporation | Hppars activators |
KR100474202B1 (ko) * | 2002-05-04 | 2005-03-08 | 강헌중 | 티아졸 유도체의 제조방법 및 이를 제조하기 위한 중간체 |
GB0214139D0 (en) | 2002-06-19 | 2002-07-31 | Glaxo Group Ltd | Chemical compounds |
US7220880B2 (en) | 2002-06-19 | 2007-05-22 | Eli Lilly And Company | Amide linker peroxisome proliferator activated receptor modulators |
US7273866B2 (en) * | 2002-12-20 | 2007-09-25 | Bristol-Myers Squibb Company | 2-aryl thiazole derivatives as KCNQ modulators |
US6933308B2 (en) | 2002-12-20 | 2005-08-23 | Bristol-Myers Squibb Company | Aminoalkyl thiazole derivatives as KCNQ modulators |
ATE382043T1 (de) * | 2003-02-14 | 2008-01-15 | Lilly Co Eli | Sulfonamid-derivate als ppar-modulatoren |
US6987118B2 (en) * | 2003-05-21 | 2006-01-17 | Pfizer Inc. | Tetrahydroisoquinoline derivatives as PPAR-alpha activators |
GB0314370D0 (en) * | 2003-06-19 | 2003-07-23 | Glaxo Group Ltd | Chemical compounds |
DE10331496A1 (de) * | 2003-07-01 | 2005-01-27 | Bayer Cropscience Ag | Verfahren zum Herstellen von Difluoracetessigsäurealkylestern |
US20050027128A1 (en) * | 2003-07-30 | 2005-02-03 | Robbins Timothy A. | Substituted thiazoles |
US7541475B2 (en) | 2003-07-30 | 2009-06-02 | Abbott Laboratories | Substituted thiazoles |
TW200526588A (en) * | 2003-11-17 | 2005-08-16 | Smithkline Beecham Corp | Chemical compounds |
JP2007230868A (ja) * | 2004-03-30 | 2007-09-13 | Dai Ichi Seiyaku Co Ltd | 二環性化合物及びそれを用いた医薬 |
WO2005095364A1 (ja) * | 2004-03-30 | 2005-10-13 | Daiichi Pharmaceutical Co. Ltd. | フェノキシ酢酸誘導体及びそれを用いた医薬 |
DE102004016845A1 (de) * | 2004-04-07 | 2005-10-27 | Bayer Healthcare Ag | Phenylthioessigsäure-Derivate und ihre Verwendung |
JP2007532511A (ja) * | 2004-04-09 | 2007-11-15 | スミスクライン ビーチャム コーポレーション | 低用量医薬品 |
JP2007284352A (ja) * | 2004-08-05 | 2007-11-01 | Dai Ichi Seiyaku Co Ltd | ピラゾール誘導体 |
KR20070050475A (ko) * | 2004-08-11 | 2007-05-15 | 교린 세이야꾸 가부시키 가이샤 | 신규 환상 아미노 안식향산 유도체 |
BRPI0606997A2 (pt) * | 2005-02-15 | 2009-07-28 | Hoffmann La Roche | compostos, processo para a sua manufatura, composições farmacêuticas que os contêm, método para o tratamento e/ou prevenção de enfermidades que são moduladas por agonistas ppar(delta) e/ou ppar(alfa) e utilização dos compostos |
CN101189231B (zh) * | 2005-03-23 | 2011-05-18 | 杏林制药株式会社 | 环状氨基苯基链烷酸衍生物 |
JP3795515B1 (ja) | 2005-08-10 | 2006-07-12 | 善典 中川 | 半導体光電気化学セルの製造方法 |
MX2008013292A (es) | 2006-04-18 | 2008-11-14 | Nippon Chemiphar Co | Agente activador para el receptor ? activado por el proliferador de peroxisoma. |
WO2008035359A2 (en) * | 2006-06-12 | 2008-03-27 | Cadila Healthcare Limited | Oximinophenoxyalkanoic acid and phenylalkanoic acid derivatives |
EP2061767B1 (de) | 2006-08-08 | 2014-12-17 | Sanofi | Arylaminoaryl-alkyl-substituierte Imidazolidin-2,4-dione, Verfahren zu ihrer Herstellung, diese Verbindungen enthaltende Arzneimittel und ihre Verwendung |
CN101790512A (zh) | 2007-03-08 | 2010-07-28 | 阿尔比里奥公司 | 2-取代-3-苯基丙酸衍生物及其在炎性肠病治疗中的用途 |
UA105758C2 (uk) * | 2007-07-19 | 2014-06-25 | Х. Луннбек А/С | 5-членні гетероциклічні аміди та споріднені сполуки |
KR100882261B1 (ko) | 2007-07-25 | 2009-02-06 | 삼성전기주식회사 | 인쇄회로기판의 제조 방법 및 장치 |
EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
DE102007054497B3 (de) | 2007-11-13 | 2009-07-23 | Sanofi-Aventis Deutschland Gmbh | Neue kristalline Diphenylazetidinonhydrate und Verfahren zu deren Herstellung |
US8648208B2 (en) | 2008-04-15 | 2014-02-11 | Nippon Chemiphar Co. Ltd. | Activating agent for peroxisome proliferator activated receptor |
US8470841B2 (en) | 2008-07-09 | 2013-06-25 | Sanofi | Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof |
WO2010068601A1 (en) | 2008-12-08 | 2010-06-17 | Sanofi-Aventis | A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof |
WO2010071813A1 (en) * | 2008-12-19 | 2010-06-24 | Aryx Therapeutics, Inc. | AGONISTS OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR-α |
RU2012111354A (ru) | 2009-08-26 | 2013-10-10 | Санофи | Новые кристаллические гидраты фторгликозидов, содержащие их фармацевтические препараты и их использование |
WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
US8247436B2 (en) | 2010-03-19 | 2012-08-21 | Novartis Ag | Pyridine and pyrazine derivative for the treatment of CF |
WO2011157827A1 (de) | 2010-06-18 | 2011-12-22 | Sanofi | Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen |
US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
EP2683705B1 (de) | 2011-03-08 | 2015-04-22 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
EP2683700B1 (de) | 2011-03-08 | 2015-02-18 | Sanofi | Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
WO2012120053A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
US8710050B2 (en) | 2011-03-08 | 2014-04-29 | Sanofi | Di and tri- substituted oxathiazine derivatives, method for the production, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
WO2012120052A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
EP2760862B1 (de) | 2011-09-27 | 2015-10-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridin-4-carbonsäureamidderivate als kinaseinhibitoren |
CN109810071B (zh) * | 2019-03-28 | 2023-04-21 | 中国科学院成都生物研究所 | 一种miRNA生物合成抑制剂 |
CN110803996B (zh) * | 2019-11-13 | 2022-01-11 | 台州市创源工业技术有限公司 | 一种羟基苄胺的合成方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9606805D0 (en) * | 1996-03-30 | 1996-06-05 | Glaxo Wellcome Inc | Medicaments |
AU738134B2 (en) * | 1997-10-02 | 2001-09-06 | Sankyo Company Limited | Amidocarboxylic acid derivatives |
US6506757B1 (en) | 1998-03-10 | 2003-01-14 | Ono Pharmaceutical Co., Ltd. | Carboxylic acid derivatives and drugs containing the same as the active ingredient |
-
2000
- 2000-11-28 PE PE2000001264A patent/PE20011010A1/es not_active Application Discontinuation
- 2000-11-29 TW TW089125344A patent/TW555753B/zh active
- 2000-11-30 CA CA002393190A patent/CA2393190A1/en not_active Abandoned
- 2000-11-30 PT PT00983189T patent/PT1244642E/pt unknown
- 2000-11-30 MX MXPA02005456A patent/MXPA02005456A/es active IP Right Grant
- 2000-11-30 AT AT00983189T patent/ATE265442T1/de not_active IP Right Cessation
- 2000-11-30 ES ES00983189T patent/ES2219423T3/es not_active Expired - Lifetime
- 2000-11-30 TR TR2002/01473T patent/TR200201473T2/xx unknown
- 2000-11-30 CZ CZ20021903A patent/CZ20021903A3/cs unknown
- 2000-11-30 IL IL14958200A patent/IL149582A0/xx active IP Right Grant
- 2000-11-30 PL PL00356772A patent/PL356772A1/xx unknown
- 2000-11-30 CO CO00091770A patent/CO5251452A1/es not_active Application Discontinuation
- 2000-11-30 AU AU20030/01A patent/AU758758B2/en not_active Ceased
- 2000-11-30 HU HU0203532A patent/HUP0203532A3/hu unknown
- 2000-11-30 EP EP00983189A patent/EP1244642B1/de not_active Expired - Lifetime
- 2000-11-30 AR ARP000106321A patent/AR035631A1/es unknown
- 2000-11-30 DK DK00983189T patent/DK1244642T3/da active
- 2000-11-30 US US10/148,765 patent/US6518290B1/en not_active Expired - Fee Related
- 2000-11-30 WO PCT/EP2000/011995 patent/WO2001040207A1/en active IP Right Grant
- 2000-11-30 CN CNB008166315A patent/CN1184215C/zh not_active Expired - Fee Related
- 2000-11-30 JP JP2001541891A patent/JP3884290B2/ja not_active Expired - Fee Related
- 2000-11-30 TR TR2004/01772T patent/TR200401772T4/xx unknown
- 2000-11-30 DE DE60010333T patent/DE60010333T2/de not_active Expired - Lifetime
- 2000-11-30 KR KR1020027007081A patent/KR100706735B1/ko not_active IP Right Cessation
- 2000-11-30 BR BR0016067-9A patent/BR0016067A/pt not_active Application Discontinuation
- 2000-12-02 GC GCP20001073 patent/GC0000215A/en active
-
2002
- 2002-05-09 IL IL149582A patent/IL149582A/en not_active IP Right Cessation
- 2002-05-24 NO NO20022467A patent/NO323135B1/no not_active IP Right Cessation
- 2002-12-14 HK HK02109084.6A patent/HK1047435B/zh not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60010333D1 (de) | Substituierte oxazole und thiazole derivate als hppar-alpha aktivatore | |
ATE264313T1 (de) | Substituierte oxazole und thiazole derivate als hppar-gamma und hppar-alpha aktivatore | |
DE60032601D1 (de) | Als antikrebsmittel verwendbare heterocyklische derivate | |
DE69920009D1 (de) | Isothiazole derivate verwendbar als antikrebsmittel | |
DE60020812D1 (de) | Heteroaryl-substituierte chinolin-2-on derivate verwendbar als antikrebsmittel | |
DE60031513D1 (de) | Phenyl- und pyridinyl-derivate verwendbar als neurokinin-1-antagonisten | |
NO20015899D0 (no) | Benzotiazinon- og benzoksazinonforbindelser | |
DE60005973D1 (de) | Biaryl-oxa(thia)zolderivate und ihre verwendung als ppars modulatoren | |
DK1244641T3 (da) | Thiazolylamid-derivater | |
DE60009147D1 (de) | Admantan derivate | |
NO20025978D0 (no) | Benzotiazol-derivater | |
EE200200341A (et) | Asendatud oksasolidinoonid ja nende kasutamine | |
NO20013369D0 (no) | Arylpiperazinyl-cykloheksyl-indol-derivater for behandling av depresjon | |
ATE273962T1 (de) | 5-phenyl-pyrimidine derivate | |
ATE233746T1 (de) | Thiazole derivate | |
DK1226131T3 (da) | Isoxazolcarboxamidderivater | |
DE69903143D1 (de) | Chromanon und thiochromanon derivate | |
ATE259362T1 (de) | Indolylpiperidinderivate als antihistaminische und antiallergische mittel | |
ATE247653T1 (de) | Thiazolidindionderivat und seine verwendung als antidiabetikum | |
ATE254621T1 (de) | Thienoisoxazolyl- und thienylpyrazolyl-phenoxy substituierte propyl derivate als d4 antagonisten | |
PT1246817E (pt) | Derivados de 4-fenil-1-piperazinilo, -piperidinilo e -tetra-hidropiridilo | |
ATE317389T1 (de) | 4-phenyl-pyrimidine derivate | |
DE60003072D1 (de) | Thiazolidindion-derivate als antidiabetika | |
DE60004451D1 (de) | Isothiazolonkonzentrate | |
ATE266012T1 (de) | Thiazole derivate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8327 | Change in the person/name/address of the patent owner |
Owner name: SMITHKLINE BEECHAM CORP., PHILADELPHIA, PA., US |
|
8328 | Change in the person/name/address of the agent |
Representative=s name: HOFFMANN & EITLE, 81925 MUENCHEN |
|
8364 | No opposition during term of opposition |